Table 2. Uptake rates and distribution of 201Tl in the soleus muscle.
C | HS | ST | HSB | STB | ||
---|---|---|---|---|---|---|
Uptake rates (%dose/g) | 0.45 ± 0.09 | 0.18 ± 0.09* | 0.15 ± 0.12* | 0.13 ± 0.05* | 0.12 ± 0.07* | |
| ||||||
Distributions (%) | 0–25% | 19.9 ± 5.9 | 19.7 ± 6.1 | 19.2 ± 2.7 | 24.9 ± 4.6 | 19.7 ± 3.4 |
25–50% | 31.6 ± 3.1§ | 33.8 ± 3.9§ | 32.7 ± 2.0§ | 31.3 ± 3.3 | 30.1 ± 5.2§ | |
50–75% | 31.8 ± 5.4§ | 28.7 ± 6.7§ | 31.3 ± 1.4§ | 27.3 ± 5.1 | 32.1 ± 3.4§ | |
75–100% | 16.7 ± 4.0¶† | 17.8 ± 3.7¶† | 16.8 ± 4.0¶† | 16.5 ± 3.5¶† | 18.1 ± 4.1¶† |
Uptake rates are expressed as percentages of administered dose taken up per gram of wet tissue weight (%dose/g). Distributions are expressed as percentage of 201Tl uptake of the region in total uptake of the muscle. Values are means±S.D.
p < 0.05 compared with C (control) group,
p < 0.05 compared with the 0–25%,
p < 0.05 compared with the 25–50%,
p < 0.05 compared with the 50–75% region.